Cart
0

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery (Glaucoma in Conjunction with Cataract, and Stand-Alone Glaucoma), Target (Trabecular Meshwork, Suprachoroidal Space, and Others), Product (MIGS Stents, MIGS Shunts, and Other) and End User (Eye Hospitals, Ophthalmology Clinics, and Outpatient Surgical Centers) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_184547
Pages: 200
Jan 2018 | 1733 Views
 
Author's : Tanvi Sapatnekar & Garima Chandra
Tables: 140
Charts: 30
 

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview:

The Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market was valued at $144 million in 2016, and is expected to reach $912 million by 2023, registering a CAGR of 30.1% from 2017 to 2023. Minimally invasive glaucoma surgery (MIGS) devices can be are employed in any glaucoma surgery that avoids conjunctival dissection, and includes an ab interno incision for the treatment of patients suffering from glaucoma. The advent of MIGS devices has transformed the patients care with mild-to-moderate glaucoma conditions. In addition, improved safety profile as well as less time required for recovery after surgery as compared to more invasive techniques increases the demand for MIGS devices. This propels manufacturers to introduce efficient MIGS devices such as stents, shunts, and minimally invasive implants in the market. Moreover, glaucoma is the primary cause of irreversible blindness across the globe, and it was estimated that around 4% of the global population suffered from glaucoma in 2014. This has increased the demand for MIGS devices in the treatment of glaucoma.

The key factors that boost the market growth include rise in burden of geriatric population that is susceptible to glaucoma. In addition, meta-analysis performed in 2014 concluded that number of people suffering from glaucoma is projected to increase over the years especially in the countries of Asia-Pacific, and Africa. Moreover, rise in demand for surgeries combining glaucoma, and cataract boosts the market growth.

However, unfavorable reimbursement for minimally invasive glaucoma surgery devices is anticipated to hamper the market growth. Further, high preference displayed by patients for surgical treatment of glaucoma as compared to glaucoma medications offers lucrative opportunities for the growth of the market.

Get more information on this report : Request Sample Pages

Surgery Segment Review

Based on surgery, the minimally invasive glaucoma surgery (MIGS) devices market is divided into glaucoma in conjunction with cataract and stand-alone glaucoma. Glaucoma in conjunction with cataract segment dominates the global MIGS market in 2016, and is anticipated to maintain this dominance throughout the forecast period. However, increase in research on the potential of stents in reducing the IOP during stand-alone glaucoma surgeries is witnessed in the recent years. This contributes to the robust growth of the stand-alone glaucoma surgeries segment in the global MIGS devices market.

Get more information on this report : Request Sample Pages

Product Form Segment Review

The minimally invasive glaucoma surgery (MIGS) devices market segmented based on product, is divided into MIGS stents, MIGS shunts, and other. Other products utilized in minimally invasive glaucoma surgeries include new laser procedures, micro implants, and microcatheters. MIGS stents segment generated the highest revenue in 2016, and is anticipated to maintain the trend throughout the forecast period. Stents are utilized on large scale in the minimally invasive glaucoma surgeries. The most widely accepted stents include iStent (Glaukos Coproration), CyPass MicroStent (Alcon/Novartis), and Hydrus Microstent (Irvine).

Get more information on this report : Request Sample Pages

Based on geography, the minimally invasive glaucoma surgery (MIGS) devices market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market accounting for highest share in 2016, and is anticipated to continue its dominance throughout the forecast period. Whereas, Asia-Pacific registered fastest growth from 2017 to 2023.

The report provides a comprehensive analysis of the key players operating in the global minimally invasive glaucoma surgery (MIGS) devices market such as Alcon Inc. (Novartis), Ellex Medical Lasers Ltd., Glaukos Corporation, Allergan Plc, Santen Pharmaceutical Co., Ltd., Lumenis, Ivantis, Inc., SOLX, Inc, iSTAR Medical, and InnFocus Inc. The other players in the value chain include Bausch & Lomb Inc., Neomedix Corporation, IOPtima, Abbott Medical Optics, Inc., Topcon Corporation, New World Medical, Inc, Carl-Zeiss AG, and Optonol Ltd.

Key Benefits

  • The study provides an in-depth analysis with the current trends and future estimations of the global minimally invasive glaucoma surgery (MIGS) devices market to elucidate the imminent investment pockets.
  • Comprehensive analysis of the factors that drive and restrict the market growth is provided.
  • The quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of key segments of the industry is provided to understand the types of minimally invasive glaucoma surgery (MIGS) devices used globally.
  • Key players and their strategies are analyzed to understand the competitive outlook of the market.

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Key Segments:

By Surgery

  • Glaucoma in Conjunction with Cataract
  • Stand Alone Glaucoma

By Target

  • Trabecular Meshwork
  • Suprachoroidal Space
  • Others

By Product

  • MIGS Stents
  • MIGS Shunts
  • Other

By End User

  • Eye Hospitals
  • Ophthalmology Clinics
  • Outpatient Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Turkey
    • Saudi Arabia
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. TOP PLAYER POSITIONING, 2016
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Rise in the geriatric population along with increasing prevalence of glaucoma worldwide
3.5.1.2. Increase in focus of key players in the development of MIGS stents
3.5.1.3. Rise in the demand for combined glaucoma and cataract surgeries

3.5.2. Restraints

3.5.2.1. Reimbursement barriers regarding MIGS devices
3.5.2.2. Dearth of skilled professionals

3.5.3. Opportunities

3.5.3.1. Rapid transition from glaucoma medications to minimally invasive glaucoma surgeries

Chapter: 4 MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. GLAUCOMA IN CONJUNCTION WITH CATARACT

4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast

4.3. STAND-ALONE GLAUCOMA

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast

Chapter: 5 MINIMALLY INVASIVE GLAUCOMA TARGET (MIGS) DEVICES MARKET, BY TARGET

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. TRABECULAR MESHWORK

5.2.1. Market size and forecast

5.3. SUPRACHOROIDAL SPACE

5.3.1. Market size and forecast

5.4. OTHERS

5.4.1. Market size and forecast

Chapter: 6 MINIMALLY INVASIVE GLAUCOMA PRODUCT (MIGS) DEVICES MARKET, BY PRODUCT

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. MIGS STENTS

6.2.1. Market size and forecast

6.3. MIGS SHUNTS

6.3.1. Market size and forecast

6.4. OTHER (TRABECTOME/MICRO-IMPLANTS/MICRO-CATHETERS)

6.4.1. Market size and forecast

Chapter: 7 MINIMALLY INVASIVE GLAUCOMA END USER (MIGS) DEVICES MARKET, BY END USER

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. EYE HOSPITALS

7.2.1. Market size and forecast

7.3. OPHTHALMOLOGY CLINICS

7.3.1. Market size and forecast

7.4. OUTPATIENT SURGICAL CENTERS

7.4.1. Market size and forecast

Chapter: 8 MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends and opportunities
8.2.2. North America Market size & forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Country
8.2.3. North America Market Size & Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.2.4. North America Market Size & Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.2.5. North America Market Size & Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.2.6. North America Market Size & Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User

8.2.6.1. U.S. Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.2.6.2. U.S. Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.2.6.3. U.S. Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.2.6.4. U.S. Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User
8.2.6.5. Canada Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.2.6.6. Canada Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.2.6.7. Canada Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.2.6.8. Canada Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User
8.2.6.9. Mexico Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.2.6.10. Mexico Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.2.6.11. Mexico Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.2.6.12. Mexico Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User

8.3. EUROPE

8.3.1. Key market trends and opportunities
8.3.2. Europe Market size & forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Country
8.3.3. Europe Market Size & Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.3.4. Europe Market Size & Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.3.5. Europe Market Size & Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.3.6. Europe Market Size & Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User

8.3.6.1. Germany Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.3.6.2. Germany Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.3.6.3. Germany Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.3.6.4. Germany Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User
8.3.6.5. France Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.3.6.6. France Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.3.6.7. France Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.3.6.8. France Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User
8.3.6.9. UK Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.3.6.10. UK Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.3.6.11. UK Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.3.6.12. UK Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User
8.3.6.13. Italy Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.3.6.14. Italy Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.3.6.15. Italy Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.3.6.16. Italy Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User
8.3.6.17. Spain Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.3.6.18. Spain Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.3.6.19. Spain Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.3.6.20. Spain Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User
8.3.6.21. Rest of Europe Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.3.6.22. Rest of Europe Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.3.6.23. Rest of Europe Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.3.6.24. Rest of Europe Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User

8.4. ASIA-PACIFIC

8.4.1. Key market trends and opportunities
8.4.2. Asia-Pacific Market size & forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Country
8.4.3. Asia-Pacific Market Size & Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.4.4. Asia-Pacific Market Size & Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.4.5. Asia-Pacific Market Size & Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.4.6. Asia-Pacific Market Size & Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User

8.4.6.1. Japan Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.4.6.2. Japan Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.4.6.3. Japan Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.4.6.4. Japan Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User
8.4.6.5. China Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.4.6.6. China Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.4.6.7. China Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.4.6.8. China Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User
8.4.6.9. Australia Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.4.6.10. Australia Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.4.6.11. Australia Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.4.6.12. Australia Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User
8.4.6.13. India Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.4.6.14. India Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.4.6.15. India Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.4.6.16. India Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User
8.4.6.17. South Korea Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.4.6.18. South Korea Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.4.6.19. South Korea Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.4.6.20. South Korea Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User
8.4.6.21. Rest of Asia-Pacific Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.4.6.22. Rest of Asia-Pacific Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.4.6.23. Rest of Asia-Pacific Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.4.6.24. Rest of Asia-Pacific Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User

8.5. LAMEA

8.5.1. Key market trends and opportunities
8.5.2. LAMEA Market size & forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Country
8.5.3. LAMEA Market Size & Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.5.4. LAMEA Market Size & Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.5.5. LAMEA Market Size & Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.5.6. LAMEA Market Size & Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User

8.5.6.1. Brazil Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.5.6.2. Brazil Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.5.6.3. Brazil Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.5.6.4. Brazil Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User
8.5.6.5. Turkey Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.5.6.6. Turkey Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.5.6.7. Turkey Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.5.6.8. Turkey Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User
8.5.6.9. Saudi Arabia Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.5.6.10. Saudi Arabia Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.5.6.11. Saudi Arabia Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.5.6.12. Saudi Arabia Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User
8.5.6.13. South Africa Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.5.6.14. South Africa Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.5.6.15. South Africa Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.5.6.16. South Africa Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User
8.5.6.17. Rest of LAMEA Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Surgery
8.5.6.18. Rest of LAMEA Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Target
8.5.6.19. Rest of LAMEA Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by Product
8.5.6.20. Rest of LAMEA Market Size and Forecast for Minimally invasive glaucoma surgery (MIGS) devices Market by End User

Chapter: 9: COMPANY PROFILES

9.1. NOVARTIS INTERNATIONAL AG (ALCON INC.)

9.1.1. Company overview
9.1.2. Operating business segments
9.1.3. Product portfolio
9.1.4. Business performance
9.1.5. Key strategic moves and developments

9.2. ALLERGAN PLC.

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance
9.2.6. Key strategic moves and developments

9.3. ELLEX MEDICAL LASERS LTD.

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments

9.4. GLAUKOS CORPORATION

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments

9.5. ISTAR MEDICAL SA

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Product portfolio
9.5.4. Key strategic moves and developments

9.6. IVANTIS INC.

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Product portfolio
9.6.4. Key strategic moves and developments

9.7. LUMENIS LTD.

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio

9.8. SANTEN PHARMACEUTICAL CO., LTD.

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.8.6. Key strategic moves and developments

9.9. SOLX, INC.

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Product portfolio
9.9.4. Key strategic moves and developments

LIST OF TABLES

TABLE 1. MIGS DEVICES: MANUFACTURERS
TABLE 2. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 3. GLOBAL MINIMALLY INVASIVE GLAUCOMA IN CONJUNCTION WITH CATARACT SURGERY DEVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL MINIMALLY INVASIVE STAND-ALONE GLAUCOMA SURGERY DEVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL MINIMALLY INVASIVE GLAUCOMA TARGET (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 6. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET FOR TRABECULAR MESHWORK, BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET FOR SUPRACHOROIDAL SPACE, BY REGION, 2016-2023 ($MILLION)
TABLE 8. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET FOR OTHERS, BY REGION, 2016-2023 ($MILLION)
TABLE 9. GLOBAL MINIMALLY INVASIVE GLAUCOMA PRODUCT (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 10. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) STENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) SHUNTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 12. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) OTHER MARKET, 2016-2023 ($MILLION)
TABLE 13. GLOBAL MINIMALLY INVASIVE GLAUCOMA END USER (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 14. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET FOR EYE HOSPITALS, BY REGION, 2016-2023 ($MILLION)
TABLE 15. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET FOR OPHTHALMOLOGY CLINICS, BY REGION, 2016-2023 ($MILLION)
TABLE 16. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET FOR OUTPATIENT SURGICAL CENTERS, BY REGION, 2016-2023 ($MILLION)
TABLE 17. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 18. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 19. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 20. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 21. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 22. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 23. U.S. MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 24. U.S. MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 25. U.S. MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 26. U.S. MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 27. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 28. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 29. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 30. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 31. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 32. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 33. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 34. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 35. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 36. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 37. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 38. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 39. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 40. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 41. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 42. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 43. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 44. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 45. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 46. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 47. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 48. UK MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 49. UK MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 50. UK MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 51. UK MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 52. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 53. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 54. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 55. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 56. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 57. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 58. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 59. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 60. REST OF EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 61. REST OF EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 62. REST OF EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 63. REST OF EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 64. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 65. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 66. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 67. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 68. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 69. JAPAN MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 70. JAPAN MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 71. JAPAN MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 72. JAPAN MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 73. CHINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 74. CHINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 75. CHINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 76. CHINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 77. AUSTRALIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 78. AUSTRALIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 79. AUSTRALIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 80. AUSTRALIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 81. INDIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 82. INDIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 83. INDIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 84. INDIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 85. SOUTH KOREA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 86. SOUTH KOREA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 87. SOUTH KOREA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 88. SOUTH KOREA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 89. REST OF ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 90. REST OF ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 91. REST OF ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 92. REST OF ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 93. LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 94. LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 95. LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 96. LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 97. LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 98. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 99. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 100. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 101. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 102. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 103. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 104. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 105. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 106. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 107. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 108. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 109. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 110. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 111. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 112. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 113. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 114. REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY, 2016-2023 ($MILLION)
TABLE 115. REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2016-2023 ($MILLION)
TABLE 116. REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 117. REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 118. NOVARTIS AG: COMPANY SNAPSHOT
TABLE 119. NOVARTIS: OPERATING SEGMENTS
TABLE 120. NOVARTIS AG: PRODUCT PORTFOLIO
TABLE 121. ALLERGAN: COMPANY SNAPSHOT
TABLE 122. ALLERGAN: OPERATING SEGMENTS
TABLE 123. ALLERGAN: PRODUCT PORTFOLIO
TABLE 124. ELLEX: COMPANY SNAPSHOT
TABLE 125. ELLEX: OPERATING SEGMENTS
TABLE 126. ELLEX: PRODUCT PORTFOLIO
TABLE 127. GLAUKOS: COMPANY SNAPSHOT
TABLE 128. GLAUKOS: PRODUCT PORTFOLIO
TABLE 129. ISTAR MEDICAL SA: COMPANY SNAPSHOT
TABLE 130. ISTAR MEDICAL SA: PRODUCT PORTFOLIO
TABLE 131. IVANTIS: COMPANY SNAPSHOT
TABLE 132. IVANTIS: PRODUCT PORTFOLIO
TABLE 133. LUMENIS: COMPANY SNAPSHOT
TABLE 134. LUMENIS: OPERATING SEGMENTS
TABLE 135. LUMENIS: PRODUCT PORTFOLIO
TABLE 136. SANTEN: COMPANY SNAPSHOT
TABLE 137. SANTEN: OPERATING SEGMENTS
TABLE 138. SANTEN: PRODUCT PORTFOLIO
TABLE 139. SOLX INC.: COMPANY SNAPSHOT
TABLE 140. SOLX INC.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 1. SEGMENTATION OF MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET
FIGURE 2. TOP INVESTMENT POCKETS IN GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 6. MODERATE BARGAINING POWER OF BUYERS
FIGURE 7. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 8. MODERATE THREAT OF NEW ENTRANTS
FIGURE 9. MODERATE THREAT OF SUBSTITUTION
FIGURE 10. HIGH COMPETITIVE RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2016
FIGURE 12. RESTRAINTS AND DRIVERS: GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET
FIGURE 13. SEGMENTATION OF MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY
FIGURE 14. MINIMALLY INVASIVE GLAUCOMA TARGET (MIGS) DEVICES MARKET, BY TARGET: MARKET SHARE, 2016
FIGURE 15. SEGMENTATION OF MINIMALLY INVASIVE GLAUCOMA (MIGS) DEVICES MARKET, BY PRODUCT 2016
FIGURE 16. MINIMALLY INVASIVE GLAUCOMA END USER (MIGS) DEVICES MARKET, BY END USER: SHARE, 2016
FIGURE 17. SEGMENTATION OF MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION
FIGURE 18. NOVARTIS: NET SALES, 2015-2017 ($MILLION)
FIGURE 19. NOVARTIS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 20. NOVARTIS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 21. ALLERGAN: NET SALES, 2014-2016 ($MILLION)
FIGURE 22. ALLERGAN: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 23. ELLEX: NET SALES, 2014-2016 ($MILLION)
FIGURE 24. ELLEX: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 25. ELLEX: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 26. GLAUKOS: NET SALES, 2014-2016 ($MILLION)
FIGURE 27. GLAUKOS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 28. SANTEN: NET SALES, 2015-2017 ($MILLION)
FIGURE 29. SANTEN: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 30. SANTEN: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

 

Glaucoma is the primary cause of irreversible blindness, and open-angle glaucoma is the most common type of glaucoma occurring worldwide. According to the statistical analysis published in the British Journal of Ophthalmology in 2016, primary open angle glaucoma (POAG) is the most common type of glaucoma accounting for three-quarters of all glaucoma cases. The traditional incisional procedures are associated with short-term as well as long-term complications such as treatment failure due to scarring, secondary cataracts, and endophthalmitis. Thus, minimally invasive glaucoma surgeries serve as an effective alternative approach for the treatment of glaucoma.

MIGS stents generated the highest revenue in 2016, and are anticipated to maintain their dominance throughout the forecast period. MIGS surgeries have most commonly incorporated stents that can cause a drainage of fluid into the suprachoroidal space to maintain intraocular pressure. Moreover, the preference of MIGS devices for the treatment of glaucoma has elevated over the years owing to the risk of allergies as well as infections associated with the glaucoma drugs, and too much dependency on medicines. Rise in the geriatric population along with increase in prevalence of glaucoma worldwide along with rise in focus of key players in the development of novel MIGS stents are anticipated to drive the market growth. However, reimbursement barriers regarding MIGS devices and dearth of skilled professionals hamper the market growth.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Minimally Invasive Glaucoma Surgery (MIGS) Devices Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3456
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo